Flow Cytometric Minimal Residual Disease Analysis in Acute Leukemia: Current Status

被引：0

作者：

Pulkit Rastogi

Man Updesh Singh Sachdeva

机构：

[1] Postgraduate Institute of Medical Education and Research,Department of Histopathology, Level 5, Research Block A

[2] Postgraduate Institute of Medical Education and Research,Department of Hematology, Level 5, Research Block A

来源：

Indian Journal of Hematology and Blood Transfusion | 2020年 / 36卷

关键词：

Minimal residual disease (MRD); Multi-parameter flow cytometry (MFC); Immunophenotyping;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Minimal residual disease (MRD) analysis for patients of acute leukemia has evolved as a significant prognostic factor. Based on the MRD results, the cases are risk-stratified after induction chemotherapy, and an alteration in further management is made to yield maximal therapeutic benefits. The two primary methodologies for MRD detection are multi-parameter flow cytometry (MFC) and polymerase chain reaction. MFC identifies the MRD based on characteristic ‘leukemia-associated immunophenotypes’ on the residual leukemia cells. MRD analysis by MFC is most frequently done at the post-induction stage of treatment and often can achieve a sensitivity of detecting one leukemic cell in 10,000 normal cells, or even higher at times. This review outlines the technical aspects and provides inputs on standard antibody panels used for MRD detection in B-, T-lineage acute lymphoblastic leukemias, and acute myeloid leukemia.

引用

页码：3 / 15

页数：12

共 40 条

[31] B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients [J].

Mendonca de Pontes, Roberia ;

Flores-Montero, Juan ;

Sanoja-Flores, Luzalba ;

Puig, Noemi ;

Pessoa de Magalhaes, Roberto J. ;

Corral-Mateos, Alba ;

Salgado, Anna Beatriz ;

Garcia-Sanchez, Omar ;

Perez-Moran, Jose ;

Mateos, Maria-Victoria ;

Burgos, Leire ;

Paiva, Bruno ;

te Marvelde, Jeroen ;

van der Velden, Vincent H. J. ;

Aguilar, Carlos ;

Barez, Abelardo ;

Garcia-Mateo, Aranzazu ;

Labrador, Jorge ;

Leoz, Pilar ;

Aguilera-Sanz, Carmen ;

Durie, Brian ;

van Dongen, Jacques J. M. ;

Maiolino, Angelo ;

Sobral da Costa, Elaine ;

Orfao, Alberto .

CANCERS, 2021, 13 (07)

[32] Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol [J].

V H J van der Velden ;

A van der Sluijs-Geling ;

B E S Gibson ;

J G te Marvelde ;

P G Hoogeveen ;

W C J Hop ;

K Wheatley ;

M B Bierings ;

G J Schuurhuis ;

S S N de Graaf ;

E R van Wering ;

J J M van Dongen .

Leukemia, 2010, 24 :1599-1606

[33] Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol [J].

van der Velden, V. H. J. ;

van der Sluijs-Geling, A. ;

Gibson, B. E. S. ;

Marvelde, J. G. Te ;

Hoogeveen, P. G. ;

Hop, W. C. J. ;

Wheatley, K. ;

Bierings, M. B. ;

Schuurhuis, G. J. ;

de Graaf, S. S. N. ;

van Wering, E. R. ;

van Dongen, J. J. M. .

LEUKEMIA, 2010, 24 (09) :1599-1606

[34] Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay [J].

Farren, Timothy W. ;

Sadanand, Kaushik S. ;

Agrawal, Samir G. .

FRONTIERS IN ONCOLOGY, 2020, 10

[35] Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease [J].

van Wering, ER ;

Van der Linden-Schrever, BEM ;

Szczepanski, T ;

Willemse, MJ ;

Baars, EA ;

Van Wijngaarde-Schmitz, HM ;

Kamps, WA ;

Van Dongen, JJM .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) :139-146

[36] MINIMAL RESIDUAL DISEASE AND B-CELL SUBPOPULATION MONITORING IN ACUTE B-LYMPHOBLASTIC LEUKAEMIA PATIENTS TREATED ON RALL-2016 PROTOCOL [J].

Galtseva, I., V ;

Davydova, Y. O. ;

Parovichnikova, E. N. ;

Gavrilina, O. A. ;

Troitskaya, V. V. ;

Kapranov, N. M. ;

Nikiforova, K. A. ;

Isinova, G. A. ;

Zarubina, K., I ;

Sokolov, A. N. ;

Savchenko, V. G. .

GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (02) :192-205

[37] ANALYSIS OF ACUTE MYELOID-LEUKEMIA CELLS BY FLOW-CYTOMETRY, INTRODUCING A NEW LIGHT-SCATTERING CLASSIFICATION [J].

HARADA, N ;

OKAMURA, S ;

KUBOTA, A ;

SHIMODA, K ;

IKEMATSU, W ;

KONDO, S ;

HARADA, M ;

NIHO, Y .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (09) :553-557

[38] USEFULNESS OF IMMUNOCYTOCHEMISTRY FOR PHENOTYPICAL ANALYSIS OF ACUTE-LEUKEMIA - IMPROVED FIXATION PROCEDURE AND COMPARATIVE-STUDY WITH FLOW-CYTOMETRY [J].

NAGAI, K ;

SOHDA, H ;

KURIYAMA, K ;

KAMIHIRA, S ;

TOMONAGA, M .

LEUKEMIA & LYMPHOMA, 1995, 16 (3-4) :319-327

[39] Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia [J].

Noronha, Elda Pereira ;

Sodr, Priscilla Moniz ;

Andrade, Francianne Gomes ;

Blunck, Caroline Barbieri ;

Camargo, Ricardo ;

Gimba, Etel Rodrigues Pereira ;

Pombo-de-Oliveira, Maria S. ;

Terra-Granado, Eugenia .

HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (02) :245-252

[40] Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease [J].

Verbeek, Wieke H. M. ;

Goerres, Marije S. ;

von Blomberg, B. Mary E. ;

Oudejans, Joost J. ;

Scholten, Petra E. T. ;

Hadithi, Muhammed ;

Al-Toma, Abdul ;

Schreurs, Marco W. J. ;

Mulder, Chris J. J. .

CLINICAL IMMUNOLOGY, 2008, 126 (01) :48-56

← 1 2 3 4 →